Laiba Immad

Contributing Author

Recent Articles by Laiba Immad

13 hours	Harrow, Inc. (HROW) Emerges as Eye Care Powerhouse With Biosimilars to Lucentis and Eylea HROW Insider Monkey
13 hours	Collegium Pharmaceutical, Inc. (COLL) to Present 9 Pain Studies at PAINWeek 2025 COLL Insider Monkey
13 hours	ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch ANIP Insider Monkey
13 hours	Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection AMPH Insider Monkey
13 hours	Avadel Pharmaceuticals plc (AVDL)'s LUMRYZ Sales Surge 64% in Breakout Quarter AVDL Insider Monkey
13 hours	FDA Accepts Lantheus Holdings, Inc. (LNTH)' NDA for New PSMA Imaging Agent LNTH Insider Monkey
13 hours	Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook DVAX Insider Monkey
13 hours	Novo Nordisk A/S (NVO) Wins U.S. Wegovy Approval for MASH, Expands to China Market NVO Insider Monkey
13 hours	BioCryst Pharmaceuticals, Inc. (BCRX) Q2 Revenue Soars 49%, Hits Record $163.4 Million on ORLADEYO Surge BCRX Insider Monkey
13 hours	Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access NBIX Insider Monkey
13 hours	Eli Lilly and Company (LLY)'s Oral Obesity Drug Orforglipron Achieves Breakthrough Phase 3 Results LLY Insider Monkey
13 hours	NRx Pharmaceuticals, Inc. (NRXP)' NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression NRXP +12.07% Insider Monkey
13 hours	Psyence Biomedical Ltd. (PBM) Achieves Breakthrough in High-Purity Ibogaine Production PBM Insider Monkey
14 hours	Relmada Therapeutics, Inc. (RLMD) Reports 91% Response Rate in Phase 2 Bladder Cancer Study RLMD +26.79% Insider Monkey
14 hours	Cybin Inc. (CYBN) Launches Global Phase 3 Trial for Breakthrough Depression Therapy CYBN -16.58% Insider Monkey
14 hours	GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial GHRS Insider Monkey
14 hours	Vistagen Therapeutics, Inc. (VTGN) Eyes Breakthrough with Phase 3 Social Anxiety Trial VTGN +5.39% Insider Monkey
14 hours	Bright Minds Biosciences Inc. (DRUG) Advances Phase 2 Trial for Drug-Resistant Epilepsy DRUG Insider Monkey
14 hours	Neuronetics, Inc. (STIM) Positions as Neurohealth Leader with Adolescent Breakthrough STIM -5.71% Insider Monkey
14 hours	Atai Life Sciences N.V. (ATAI)'s BPL-003 Achieves Robust Phase 2b Success in Treatment-Resistant Depression ATAI Insider Monkey
14 hours	Mind Medicine (MindMed) Inc. (MNMD)'s MM120 Earns FDA Breakthrough Status in Anxiety Treatment MNMD Insider Monkey
14 hours	COMPASS Pathways Plc (CMPS)' Psilocybin Therapy Hits Phase 3 Success in Depression CMPS Insider Monkey
14 hours	Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025 ALKS Insider Monkey
14 hours	Biogen Inc. (BIIB)'s Alzheimer's Drug Leqembi Wins EU Nod, Now Approved in 48 Countries BIIB +5.60% Insider Monkey
14 hours	Amgen Inc. (AMGN)'s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential AMGN Insider Monkey
14 hours	Bristol-Myers Squibb Company (BMY) Launches $300M Immunology Spinout with Bain Capital BMY Insider Monkey
14 hours	Gilead Sciences, Inc. (GILD) Wins FDA Approval for World's First Twice-Yearly HIV Preventive Therapy GILD Insider Monkey
14 hours	Zoetis Inc. (ZTS) Reports $2.5B Q2 Revenue, Raises Full-Year Outlook on Strong Pet Care Demand ZTS Insider Monkey
14 hours	Pfizer Inc. (PFE)'s Updated COVID-19 Vaccine COMIRNATY LP.8.1 Gets FDA Approval, Ships Nationwide PFE Insider Monkey
14 hours	AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market ABBV Insider Monkey
14 hours	Merck & Co., Inc. (MRK) Launches $3B Plan to Reinvest Ahead of Keytruda Patent Expiry in 2028 MRK Insider Monkey
14 hours	Johnson & Johnson (JNJ)'s Carvykti Sales Skyrocket 100% Amid Specialty Medicine Growth JNJ Insider Monkey
14 hours	Eli Lilly and Company (LLY) Halts UK Mounjaro Shipments Ahead of Planned Price Increase LLY Insider Monkey
Aug-29	Genmab A/S (GMAB)'s Epcoritamab Delivers 95% Response in Lymphoma GMAB Insider Monkey
Aug-29	Sanofi (SNY)'s Sarclisa Gets EMA Nod for Multiple Myeloma SNY Insider Monkey
Aug-29	MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy MDXG Insider Monkey
Aug-29	MannKind Corporation (MNKD) Seeks FDA Pediatric Approval for Afrezza MNKD Insider Monkey
Aug-29	Ardelyx, Inc. (ARDX) Strengthens Global Reach with Kyowa Kirin Deal ARDX Insider Monkey
Aug-29	Xeris Biopharma Holdings, Inc. (XERS) Reports Record $71.5M Q2 Revenue XERS Insider Monkey
Aug-29	Wave Life Sciences Ltd. (WVE) Gains Momentum With Multiple RNA Wins WVE Insider Monkey
Aug-29	Amicus Therapeutics, Inc. (FOLD) Expands Pipeline With Rare Kidney Disease Drug FOLD Insider Monkey
Aug-29	Collegium Pharmaceutical, Inc. (COLL) Highlights Real-World Evidence at PAINWeek 2025 COLL Insider Monkey
Aug-29	Ardent Health, Inc. (ARDT) Expands Footprint with 18 New Urgent Care Clinics in 2025 ARDT Insider Monkey
Aug-29	Integra LifeSciences Holdings Corporation (IART) Focuses on Supply Chain Recovery and Growth Strategy IART Insider Monkey
Aug-29	Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT Acquisition BHC Insider Monkey
Aug-29	CorMedix Inc. (CRMD) Acquires Melinta Therapeutics to Expand Hospital-Focused Portfolio CRMD Insider Monkey
Aug-29	Royalty Pharma plc (RPRX) Boosts Growth with $885M Amgen Imdelltra Royalty Deal RPRX Insider Monkey
Aug-29	Organon & Co. (OGN) Advances VTAMA Cream, Strengthens Women's Health Portfolio OGN Insider Monkey
Aug-29	Jazz Pharmaceuticals plc (JAZZ) Wins FDA Accelerated Approval for Modeyso Brain Cancer Therapy JAZZ Insider Monkey
Aug-29	Viatris, Inc. (VTRS) Achieves Key Clinical Milestones in Ophthalmology, Pain, Women's Health VTRS Insider Monkey
Aug-29	Teva Pharmaceutical Industries Limited (TEVA) Gains FDA Nod for Pediatric Migraine Drug AJOVY TEVA Insider Monkey
Aug-29	Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally GMAB Insider Monkey
Aug-29	Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA NVAX Insider Monkey
Aug-29	Harmony Biosciences Holdings, Inc. (HRMY) Expands WAKIX With FDA Nod for Prader-Willi HRMY Insider Monkey
Aug-29	Agios Pharmaceuticals, Inc. (AGIO) Advances Pipeline With Tebapivat, AG-236 in Rare Blood Disorders AGIO Insider Monkey
Aug-29	Royalty Pharma plc (RPRX) Strikes $2B Partnership with Revolution Medicines RPRX Insider Monkey
Aug-29	Catalyst Pharmaceuticals, Inc. (CPRX) Secures FIRDAPSE Market Exclusivity Until 2035 CPRX Insider Monkey
Aug-29	ACADIA Pharmaceuticals Inc. (ACAD) Nears Phase 3 Readout in Prader-Willi Syndrome Trial ACAD Insider Monkey
Aug-29	PTC Therapeutics, Inc. (PTCT) Faces FDA Setback on Vatiquinone for Friedreich's Ataxia PTCT Insider Monkey
Aug-29	Halozyme Therapeutics, Inc. (HALO) Hikes 2025 Guidance on ENHANZE Demand HALO Insider Monkey
Aug-29	Exelixis, Inc. (EXEL) Halts Phase 3 STELLAR-305 Trial EXEL Insider Monkey
Aug-29	Regeneron Pharmaceuticals, Inc. (REGN) Confident on Odronextamab Approval After Setbacks REGN Insider Monkey
Aug-28	Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults NVAX Insider Monkey
Aug-28	Recursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition RXRX Insider Monkey
Aug-28	AbCellera Biologics Inc. (ABCL) Launches First Human Trial for Menopause Therapy ABCL Insider Monkey
Aug-28	ImmunityBio, Inc. (IBRX) Targets Lymphopenia with Cancer BioShield Platform IBRX Insider Monkey
Aug-28	Merck & Co., Inc. (MRK) Expands Targeted Therapy Pipeline with ADC Advances MRK Insider Monkey
Aug-28	FDA Approves Regeneron Pharmaceuticals, Inc. (REGN)'s Linvoseltamab for Multiple Myeloma REGN Insider Monkey
Aug-28	AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025 AZN Insider Monkey
Aug-28	Incyte Corporation (INCY) Expands Precision Medicine with QIAGEN Partnership INCY Insider Monkey
Aug-28	Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine MRNA Insider Monkey
Aug-28	Arcellx, Inc. (ACLX) Reports 97% Response Rate in CAR-T Trial ACLX Insider Monkey
Aug-28	BeOne Medicines Ltd. (ONC) Unveils Promising Breast Cancer Therapies at ASCO 2025 ONC Insider Monkey
Aug-28	Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments TAK Insider Monkey
Aug-28	BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal BNTX Insider Monkey
Aug-17	Clover Health (CLOV) Achieves Profitability as Medicare Advantage Membership Surges CLOV Insider Monkey
Aug-17	GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth GDRX Insider Monkey
Aug-17	MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline MNKD Insider Monkey
Aug-17	OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics OPK Insider Monkey
Aug-17	LifeStance Health (LFST) Accelerates Growth with AI-Enabled Operations and Clinician Expansion LFST Insider Monkey
Aug-17	Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid RXRX Insider Monkey
Aug-17	Medical Properties Trust (MPW) Raises $500M to Strengthen Balance Sheet MPW Insider Monkey
Aug-17	AbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial Results ABCL Insider Monkey
Aug-17	Neogen Corp (NEOG) Beats Expectations Amid Leadership Change and Restructuring Efforts NEOG Insider Monkey
Aug-17	Tilray Brands (TLRY) Boosts Revenue Mix with New Cannabis, Wellness, and Beverage Products TLRY Insider Monkey
Aug-17	Cronos Group (CRON) Posts Double-Digit Cannabis Growth and Expands International Footprint CRON Insider Monkey
Aug-17	ImmunityBio (IBRX) Reports 60% Revenue Growth as ANKTIVA Adoption Accelerates IBRX Insider Monkey
Aug-17	Vistra (VST) Projects $6 Billion EBITDA as AI Data Centers Drive Power Demand Surge VST Insider Monkey
Aug-17	Constellation Energy (CEG) Strikes 20-Year PPA with Meta, Boosts Nuclear Expansion Plans CEG Insider Monkey
Aug-17	NextEra Energy (NEE) to Invest $120 Billion in Renewables and Storage Through 2029 NEE Insider Monkey
Aug-17	Duke Energy (DUK) Reports Nearly $1 Billion Profit, Eyes $87 Billion Growth Plan DUK Insider Monkey
Aug-02	Greenlane Holdings, Inc. (GNLN) Expands Into Health Tech with Fentanyl Safety Strips Deal GNLN Insider Monkey
Aug-02	Agrify Corporation (AGFY) Raises $25.9M to Fuel THC Beverage Expansion Insider Monkey
Aug-02	Urban-Gro, Inc. (UGRO) Lands $24M Cannabis Facility Contract Amid Growth Surge UGRO Insider Monkey
Aug-02	Canopy Growth Corporation (CGC) Growth Accelerates U.S. Expansion with Major Acquisitions CGC Insider Monkey
Aug-02	High Tide Inc. (HITI) Secures $30M from Cronos to Fuel Global Expansion HITI Insider Monkey
Aug-02	Organigram Global Inc. (OGI) Expands Into U.S. THC Beverage Market Across 25 States OGI Insider Monkey
Aug-02	Village Farms International, Inc. (VFF) Transforms Into Cannabis-Only Powerhouse VFF Insider Monkey
Aug-02	Aurora Cannabis Inc. (ACB) Becomes Medical Market Powerhouse with 93% Sales Jump ACB Insider Monkey
Aug-02	SNDL Inc. (SNDL) Expands North American Reach with $32.2M Cannabis Retail Acquisition SNDL Insider Monkey

Laiba Immad

Recent Articles by Laiba Immad

Upgrade your FINVIZ experience